Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27,946,194
-
Total 13F shares
-
35,417,634
-
Share change
-
-381,984
-
Total reported value
-
$468,934,603
-
Put/Call ratio
-
157%
-
Price per share
-
$13.24
-
Number of holders
-
133
-
Value change
-
-$87,874,690
-
Number of buys
-
66
-
Number of sells
-
85
Institutional Holders of ANAPTYSBIO, INC - Common Stock (ANAB) as of Q4 2024
As of 31 Dec 2024,
ANAPTYSBIO, INC - Common Stock (ANAB) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,417,634 shares.
The largest 10 holders included
EcoR1 Capital, LLC, FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, STATE STREET CORP, and Camber Capital Management LP.
This page lists
133
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.